Salidroside alleviates cognitive impairment by inhibiting ferroptosis via activation of the Nrf2/GPX4 axis in SAMP8 mice.

[1]  Ruihan Yang,et al.  Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway , 2022, Cell & Bioscience.

[2]  Yingwei Chen,et al.  Salidroside alleviates ulcerative colitis via inhibiting macrophage pyroptosis and repairing the dysbacteriosis‐associated Th17/Treg imbalance , 2022, Phytotherapy research : PTR.

[3]  S. Merighi,et al.  Microglia and Alzheimer’s Disease , 2022, International journal of molecular sciences.

[4]  Lei Zhou,et al.  Regulating Nrf2-GPx4 axis by bicyclol can prevent ferroptosis in carbon tetrachloride-induced acute liver injury in mice , 2022, Cell Death Discovery.

[5]  Y. Zeng,et al.  Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ1-42-induced Alzheimer’s disease mice and glutamate-injured HT22 cells , 2022, Chinese Medicine.

[6]  Hui-Zhi Long,et al.  The Role of Microglia in Alzheimer’s Disease From the Perspective of Immune Inflammation and Iron Metabolism , 2022, Frontiers in Aging Neuroscience.

[7]  Han Guo,et al.  Forsythoside A Mitigates Alzheimer's-like Pathology by Inhibiting Ferroptosis-mediated Neuroinflammation via Nrf2/GPX4 Axis Activation , 2022, International journal of biological sciences.

[8]  W. Zou,et al.  CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. , 2022, Cancer cell.

[9]  Y. Liu,et al.  Salidroside inhibits doxorubicin-induced cardiomyopathy by modulating a ferroptosis-dependent pathway. , 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[10]  B. Platt,et al.  Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model. , 2021, Journal of Alzheimer's disease : JAD.

[11]  N. Chattipakorn,et al.  Cell death inhibitors protect against brain damage caused by cardiac ischemia/reperfusion injury , 2021, Cell death discovery.

[12]  A. Bush,et al.  Ferroptosis and NRF2: an emerging battlefield in the neurodegeneration of Alzheimer's disease. , 2021, Essays in biochemistry.

[13]  A. Alexiou,et al.  Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease , 2021, Current neuropharmacology.

[14]  Yusheng Cong,et al.  Neuroprotective effects of salidroside on ageing hippocampal neurons and naturally ageing mice via the PI3K/Akt/TERT pathway , 2021, Phytotherapy research : PTR.

[15]  B. Železná,et al.  Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22 , 2021, Journal of Neuroinflammation.

[16]  Lan Zhang,et al.  Tetrahydroxy Stilbene Glucoside Ameliorates Cognitive Impairments and Pathology in APP/PS1 Transgenic Mice , 2021, Current Medical Science.

[17]  Yu Zheng,et al.  Salidroside: A review of its recent advances in synthetic pathways and pharmacological properties. , 2021, Chemico-biological interactions.

[18]  Fengna Chu,et al.  Role of Adaptive Immune and Impacts of Risk Factors on Adaptive Immune in Alzheimer’s Disease: Are Immunotherapies Effective or Off-Target? , 2021, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[19]  R. Velazquez,et al.  Sex differences in the IntelliCage and the Morris water maze in the APP/PS1 mouse model of amyloidosis , 2021, Neurobiology of Aging.

[20]  D. Tang,et al.  Characteristics and Biomarkers of Ferroptosis , 2021, Frontiers in Cell and Developmental Biology.

[21]  Shih-Ying Wu,et al.  Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung , 2021, Nature Communications.

[22]  P. Nelson,et al.  Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease , 2021, Cell Death & Differentiation.

[23]  Ting Zeng,et al.  Salidroside Attenuates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8 (SAMP8) Mice and Modulates Inflammation of the Gut-Brain Axis , 2020, Frontiers in Pharmacology.

[24]  O. Nicole,et al.  CD8+ T Cell-Mediated Mechanisms Contribute to the Progression of Neurocognitive Impairment in Both Multiple Sclerosis and Alzheimer's Disease? , 2020, Frontiers in Immunology.

[25]  A. Bush,et al.  Iron and Ferroptosis as Therapeutic Targets in Alzheimer’s Disease , 2020, Neurotherapeutics.

[26]  N. S. Yarla,et al.  Salidroside - Can it be a multifunctional drug? , 2020, Current drug metabolism.

[27]  J. Attems,et al.  CD8+ T-cells infiltrate Alzheimer’s disease brains and regulate neuronal- and synapse-related gene expression in APP-PS1 transgenic mice , 2020, Brain, Behavior, and Immunity.

[28]  Jie Liu,et al.  SAMP8 Mice as a Model of Age-Related Cognition Decline with Underlying Mechanisms in Alzheimer's Disease. , 2020, Journal of Alzheimer's disease : JAD.

[29]  Mark M. Davis,et al.  Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease , 2020, Nature.

[30]  M. Heneka.  An immune-cell signature marks the brain in Alzheimer’s disease , 2020, Nature.

[31]  David R. Brown,et al.  Microglia and the aging brain: are senescent microglia the key to neurodegeneration? , 2019, Journal of neurochemistry.

[32]  Nicola Thrupp,et al.  The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques , 2019, Cell reports.

[33]  A. Chinnaiyan,et al.  CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy , 2019, Nature.

[34]  Tao Wang,et al.  Iron Pathophysiology in Alzheimer's Diseases. , 2019, Advances in experimental medicine and biology.

[35]  S. Hébert,et al.  Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer’s disease , 2019, Journal of Neuroinflammation.

[36]  Lidian Chen,et al.  Pharmacological activities, mechanisms of action, and safety of salidroside in the central nervous system , 2018, Drug design, development and therapy.

[37]  Feng Yan,et al.  Salidroside provides neuroprotection by modulating microglial polarization after cerebral ischemia , 2018, Journal of Neuroinflammation.

[38]  R. Nitsch,et al.  Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study , 2018, Neurodegenerative Diseases.

[39]  Zhan-You Wang,et al.  α-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice , 2017, Redox biology.

[40]  I. Amit,et al.  A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease , 2017, Cell.

[41]  Yun-Sik Choi,et al.  Effect of rotation preference on spontaneous alternation behavior on Y maze and introduction of a new analytical method, entropy of spontaneous alternation , 2017, Behavioural Brain Research.

[42]  L. Buée,et al.  Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy , 2016, Brain : a journal of neurology.

[43]  Erin L. Abner,et al.  A Comprehensive Behavioral Test Battery to Assess Learning and Memory in 129S6/Tg2576 Mice , 2016, PloS one.

[44]  Na Wei,et al.  Delineating the relationships among the formation of reactive oxygen species, cell membrane instability and innate autoimmunity in intestinal reperfusion injury. , 2014, Molecular immunology.

[45]  Xiaorui Cheng,et al.  The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model , 2014, Ageing Research Reviews.

[46]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[47]  Han-Xiong Li,et al.  Production of Th1- and Th2-dependent cytokines induced by the Chinese medicine herb, Rhodiola algida, on human peripheral blood monocytes. , 2009, Journal of ethnopharmacology.

[48]  C. Belzung,et al.  The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. , 2003, European journal of pharmacology.

[49]  C. Carpi,et al.  [In vivo anihistidine-decarboxylasic activity of 2-methyl-6,7-methylendioxy-8-methoxy-1-(4', 5', 6',-triothoxy-7-aminophthalidyl)-1,2,3,4 tetrahydroisoquinoline (tritoqualine)]. , 1968, Bollettino della Societa italiana di biologia sperimentale.